{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T20:17:22Z","timestamp":1691439442074},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,10,17]],"date-time":"2014-10-17T00:00:00Z","timestamp":1413504000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["DARU J Pharm Sci"],"published-print":{"date-parts":[[2014,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>Sweet\u2019s syndrome (SS) is characterized by various clinical symptoms, physical features, and pathological findings. Although cases of SS are very rare, there has been an increase in the incidence of drug-induced SS. Till date, there have been only few reported cases of isotretinoin-induced SS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case summary<\/jats:title>\n            <jats:p>In this report, we describe the case of a 19-year-old girl who developed SS after systemic treatment with oral isotretinoin for nodulocystic acne.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The findings of this report emphasize the importance of evaluating isotretinoin as a possible, though uncommon, cause of SS and replacing it with another treatment if its involvement is suspected.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40199-014-0069-2","type":"journal-article","created":{"date-parts":[[2014,10,16]],"date-time":"2014-10-16T10:39:54Z","timestamp":1413455994000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Isotretinoin-associated Sweet\u2019s syndrome: a case report"],"prefix":"10.1186","volume":"22","author":[{"given":"Jamileh","family":"Moghimi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daryiush","family":"Pahlevan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Azizzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid","family":"Hamidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsen","family":"Pourazizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,10,17]]},"reference":[{"key":"69_CR1","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1046\/j.1365-4362.2003.01891.x","volume":"42","author":"PR Cohen","year":"2003","unstructured":"Cohen PR, Kurzrock R: Sweet\u2019s syndrome revisited: a review of disease concepts. Int J Dermatol. 2003, 42: 761-778. 10.1046\/j.1365-4362.2003.01891.x.","journal-title":"Int J Dermatol"},{"issue":"3","key":"69_CR2","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/j.1365-2133.2006.07677.x","volume":"6","author":"CY Neoh","year":"2007","unstructured":"Neoh CY, Tan AWH, Ng SK: Sweet\u2019s syndrome: a spectrum of unusual clinical presentations and associations. Br J Dermatol. 2007, 6 (3): 480-485. 10.1111\/j.1365-2133.2006.07677.x.","journal-title":"Br J Dermatol"},{"issue":"1","key":"69_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1590\/S0365-05962011000100002","volume":"86","author":"RR Bonamigo","year":"2011","unstructured":"Bonamigo RR, Razera F, Olm GS: Neutrophilic dermatoses: part I. An Bras Dermatol. 2011, 86 (1): 11-25. 10.1590\/S0365-05962011000100002.","journal-title":"An Bras Dermatol"},{"key":"69_CR4","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1345\/aph.1H563","volume":"41","author":"DF Thompson","year":"2007","unstructured":"Thompson DF, Montarella KE: Drug-induced Sweet\u2019s syndrome. Ann Pharmacother. 2007, 41: 802-811. 10.1345\/aph.1H563.","journal-title":"Ann Pharmacother"},{"key":"69_CR5","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0738-081X(99)00124-8","volume":"18","author":"JC Roujeau","year":"2000","unstructured":"Roujeau JC: Neutrophilic drug eruptions. Clin Dermatol. 2000, 18: 331-337. 10.1016\/S0738-081X(99)00124-8.","journal-title":"Clin Dermatol"},{"key":"69_CR6","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.1468-3083.2004.00866.x","volume":"18","author":"M Saez","year":"2004","unstructured":"Saez M, Garcia-Bustinduy M, Noda A, Dorta S, Escoda M, Fagundo E: Drug-induced Sweet\u2019s syndrome. J Eur Acad Derm Venereol. 2004, 18: 233-10.1111\/j.1468-3083.2004.00866.x.","journal-title":"J Eur Acad Derm Venereol"},{"key":"69_CR7","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/S0190-9622(96)90080-8","volume":"34","author":"DC Walker","year":"1996","unstructured":"Walker DC, Cohen PR: Trimethoprim-sulfamethoxazole-associated acute febrile neutrophilic dermatosis: case report and review of drug-induced Sweet\u2019s syndrome. J Am Acad Dermatol. 1996, 34: 918-923. 10.1016\/S0190-9622(96)90080-8.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"69_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/mpo.10089","volume":"40","author":"A Gyorfy","year":"2003","unstructured":"Gyorfy A, Kov\u00e1cs T, Szegedi I, Ol\u00e1h E, Kiss C: Sweet syndrome associated with 13-cis-retinoic acid (isotretinoin) therapy. Med Pediatr Oncol. 2003, 40 (2): 135-136. 10.1002\/mpo.10089.","journal-title":"Med Pediatr Oncol"},{"issue":"2","key":"69_CR9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0151-9638(07)91608-7","volume":"134","author":"D Ammar","year":"2007","unstructured":"Ammar D, Denguezli M, Ghariani N, Sriha B, Belajouza C, Nouira R: Sweet\u2019s syndrome complicating isotretinoin therapy in acne. Ann Dermatol Venereol. 2007, 134 (2): 151-154. 10.1016\/S0151-9638(07)91608-7.","journal-title":"Ann Dermatol Venereol"}],"container-title":["DARU Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40199-014-0069-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40199-014-0069-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40199-014-0069-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40199-014-0069-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T06:07:54Z","timestamp":1630562874000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40199-014-0069-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,17]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["69"],"URL":"https:\/\/doi.org\/10.1186\/s40199-014-0069-2","relation":{},"ISSN":["2008-2231"],"issn-type":[{"value":"2008-2231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,17]]},"assertion":[{"value":"7 August 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"69"}}